Erdafitinib US FDA Label
- Compound: N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine
- Description: Erdafitinib is a Kinase Inhibitor. The mechanism of action of erdafitinib is as a Fibroblast Growth Factor Receptor Inhibitor, and Cytochrome P450 3A4 Inhibitor, and Cytochrome P450 3A4 Inducer, and P-Glycoprotein Inhibitor, and Organic Cation Transporter 2 Inhibitor.
- Brand Name:
- Code(s): JNJ-42756493
- Approved:
- Kinase Class: RY
- Inhibitor Type: I ½ A
- Literature (PubMed): 0
- Target(s): fibroblast growth factor receptor 1 , fibroblast growth factor receptor 2
- Disease(s): bladder urothelial carcinoma , transitional cell carcinoma